Study 307- Long term open label extension data

Krauss GL Perucca E BenMenachem E Kwan P Shih JJ Squillacote D Yang H Gee M Zhu J Laurenza A Perampanel a selective noncompetitive AMPA receptor antagonist as adjunctive therapy for refractory partialonset seizures interim results from Phase III extension study 307

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "Study 307- Long term open label extensi..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.